Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts.
Journal:
Journal of the American Medical Informatics Association : JAMIA
PMID:
38758661
Abstract
OBJECTIVES: Linking information on Japanese pharmaceutical products to global knowledge bases (KBs) would enhance international collaborative research and yield valuable insights. However, public access to mappings of Japanese pharmaceutical products that use international controlled vocabularies remains limited. This study mapped YJ codes to RxNorm ingredient classes, providing new insights by comparing Japanese and international drug-drug interaction (DDI) information using a case study methodology.